More on ELVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Enliven Therapeutics, Inc (NQ:ELVN)
Delayed: 58.21 +0.35 (0.60%)
Prev. Close $57.86  
Open$58.36 
52 Wk High$ 
52 Wk Low$ 
Day High$60.55 
Day Low$57.36 
P/E N/A  
EPS$ 
Volume154,859 

Friends, Peers and Foes (?): ALLO, CHRS, ONCY, PYXS, MAZE (more...)

Aug 19, 2026 04:18 PM Form 4 Enliven Therapeutics, For: Aug 17 Filed by: Hohl Benjamin
Aug 19, 2026 04:16 PM Form 4 Enliven Therapeutics, For: Aug 17 Filed by: Collins Helen Louise
Aug 18, 2026 06:36 AM Enliven Therapeutics (ELVN) PT Raised to $73 at Mizuho
Aug 18, 2026 06:02 AM William Blair Starts Enliven Therapeutics (ELVN) at Outperform
Aug 18, 2026 06:00 AM Barclays Starts Enliven Therapeutics (ELVN) at Overweight
Aug 6, 2026 08:18 PM Form 4 Enliven Therapeutics, For: Aug 04 Filed by: Derynck Mika K
Aug 6, 2026 10:21 AM Form SCHEDULE 13G/A Enliven Therapeutics, Filed by: FMR LLC
Aug 6, 2026 08:29 AM Enliven Therapeutics (ELVN) PT Raised to $75 at Baird
Aug 6, 2026 08:09 AM Enliven Therapeutics (ELVN) PT Raised to $82 at Stifel
Aug 6, 2026 06:44 AM Enliven Therapeutics (ELVN) PT Lowered to $78 at Guggenheim
View All Articles

Entities mentioned with ELVN

View All Entities